Navigation Links
Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
Date:8/6/2009

---------------- EXPENSES License and royalty fees 2,568 - 2,568 Cost of products sold 25,682 (896) b 24,786 Research and development 6,833 (739) c 6,094 Selling, general and administrative 21,606 (2,548) d 19,058 Depreciation and amortization 8,296 (7,453) e 843 --------------------------------- --------------------------------------- 64,985 (11,636) 53,349 --------------------------------- --------------------------------------- Operating (loss) income (412) 11,238 10,826 --------------------------------- --------------------------------------- Other income (expenses): Foreign exchange (loss) gain (1,441) 1,441 f - Investment and other income (loss) (600) 636 g 36 Loss on sale/write-down of investments - - - Interest expense on long-term debt (9,641) 750 i (8,891) --------------------------------- --------------------------------------- --------------------------------- --------------------------------------- (11,682) 2,827 (8,855) --------------------------------- --------------------------------------- --------------------------------- --------------------------------------- (Loss) income before income taxes (12,094) 14,065 1,971 Income tax (recovery) expense (217) 3,960 j 3,743 --------------------------------- --------------------------------------- --------------------------------- --------------------------------------- Net loss for the period (11,877) 10,105 (1,772) --------
'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related biology technology :

1. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
2. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
3. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
4. Angiotech to participate in UBS Global Life Sciences Conference
5. Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
6. Angiotech Receives CE Mark Approval of Quill(TM) SRS MONODERM(TM), a New Rapidly Resorbing Suture Product Line
7. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
8. Angiotech to participate in Bank of America 2007 Credit Conference
9. Angiotech to participate in RBC 2007 Healthcare Conference
10. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
11. Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 25, 2014 Global biostimulants market ... growing at an estimated CAGR of 12.5%. In ... food products with least ecological impacts, farmers are ... to boost crop yield more effectively & efficiently. ... can improve the return on investments. , Leading ...
(Date:11/26/2014)... DE (PRWEB) November 26, 2014 ... Heroes recognition reception on December 5, 2014, in San ... meeting. The MPN Heroes event will honor clinicians, caregivers, ... field of myeloproliferative neoplasms (MPNs). , Special guest ... discuss his family's cancer journey at the reception. ...
(Date:11/26/2014)... , Nov. 25, 2014 Bio-Techne Corporation ... has appointed Robert Gavin to serve in ... the Protein Platforms Division.  Mr. Gavin will be responsible ... segment, which includes the ProteinSimple business acquired in July ... San Jose, California -based ProteinSimple develops ...
(Date:11/24/2014)... BUENA, N.J. , Nov. 24, 2014  IGI ... Jersey based specialty generic pharmaceutical company, today ... application (ANDA) to the U.S. Food and Drug Administration ... submissions in 2014 to seven, with eighteen submissions now ... Grenfell-Gardner , President and CEO of the Company, commented, ...
Breaking Biology Technology:2019 Biostimulants Market to Grow at a CAGR of 12.5% Says a New Research Report Available at RnRMarketResearch.com 22019 Biostimulants Market to Grow at a CAGR of 12.5% Says a New Research Report Available at RnRMarketResearch.com 32019 Biostimulants Market to Grow at a CAGR of 12.5% Says a New Research Report Available at RnRMarketResearch.com 4CURE Magazine and Incyte to Honor MPN Heroes 2CURE Magazine and Incyte to Honor MPN Heroes 3CURE Magazine and Incyte to Honor MPN Heroes 4Bio?Techne Announces Appointment Of Robert Gavin As Leader Of New Protein Platforms Division 2Bio?Techne Announces Appointment Of Robert Gavin As Leader Of New Protein Platforms Division 3IGI Laboratories, Inc. Announces ANDA Submission 2
... 5 /Xinhua-PRNewswire/ -- China-Biotics, Inc. (OTC,Bulletin Board: ... specializing in the manufacture, research, development, marketing ... third quarter,fiscal 2008 earnings conference call previously ... held at 9 a.m. EST on Wednesday, ...
... DiObex, Inc., a privately held,biotechnology company focused on the ... CEO David Cory will deliver a,corporate presentation at the ... Medical Device Conference in New York,New York. The DiObex ... a.m. at the Grand Hyatt Hotel in the Broadway ...
... EntreMed, Inc.,(Nasdaq: ENMD ) a clinical-stage pharmaceutical ... inflammatory diseases, today,announced that James S. Burns, President ... at the BIO CEO and Investor Conference, to ... Mr. Burns,presentation is scheduled for Tuesday, February 12, ...
Cached Biology Technology:China-Biotics, Inc. Announces Rescheduling of Conference Call to Discuss Third Quarter 2008 Results 2China-Biotics, Inc. Announces Rescheduling of Conference Call to Discuss Third Quarter 2008 Results 3EntreMed to Present at BIO CEO and Investor Conference 2
(Date:11/4/2014)... In nature, the right amount of death at the ... density, according to new research that could help in ... wildlife stocks. , In a paper in the journal ... University researcher and European colleagues conclude that the kind ... a loss of individuals, or mortality, depends on the ...
(Date:11/4/2014)... A newly published research study examining only marketing ... of fast food restaurants has found that the ... disproportionately exposed to such marketing tactics. , Authored ... her colleagues, the study is the first to ... interior and exterior of fast food restaurants and ...
(Date:11/4/2014)... 4, 2014   Neurotechnology , a provider ... the latest version of its fingerprint matching algorithm ... MINEX evaluation organized by NIST. The MINEX ... the INCITS 378 fingerprint standard template format. MINEX ... tenders in the United States ...
Breaking Biology News(10 mins):When less is more: Death in moderation boosts population density in nature 2Fast food marketing for children disproportionately affects certain communities 2Fast food marketing for children disproportionately affects certain communities 3Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 2Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 3
... and New Brunswick, NJ, November 19, 2007 Raydiance, ... innovative collaboration with Rutgers University and the Musculoskeletal Transplant ... the science of dermal tissue processing. In ... a new type of laser developed on the Raydiance ...
... most of their day sitting with relatively idle muscles. ... activity at least 5 days a week will counteract ... that may result from inactivity. Now, researchers at the ... activity recommendations is emerging. New research shows that what ...
... can pay big dividends to aging baby boomers who want ... division of geriatric medicine at Saint Louis University, in a ... of life as we age. Living well and feeling ... your lifetime is priceless, says Morley, who is coauthor of ...
Cached Biology News:Raydiance collaborates with Rutgers, MTF to develop innovative tissue processing approaches 2MU study finds that sitting may increase risk of disease 2MU study finds that sitting may increase risk of disease 3Eat chocolate, drink wine, add fun to life: SLU geriatrician shares secrets of staying young 2Eat chocolate, drink wine, add fun to life: SLU geriatrician shares secrets of staying young 3Eat chocolate, drink wine, add fun to life: SLU geriatrician shares secrets of staying young 4
... strength adhesive system which facilitates the easy removal ... either side of the frame are of differing ... has an easy release adhesive whereas the reverse, ... bond. This means that when the coverslip is ...
... processing offering reproducibility, reliability and in-built ... automation and massive parallel analysis makes ... many applications in both industrial and ... gene expression profiling, gene regulation and ...
The Piezo Power MicroDissection (PPMD) system is designed for rapid isolation of single cells or small cell areas...
... is a high quality microarray scanner based on ... rejection and spatial resolution. The DNAscope LM ... cost microarray scanner that is upgradeable to a ... Features: Includes control module (computer), ...
Biology Products: